Shuang Zhao Xinghong Xian Panwen Tian Weimin Li Ke Wang Yalun Li
10.3389/fonc.2021.633522
Front Oncol
2021 Apr 20;11:633522.
chemotherapy human epidermal growth factor receptor2 immunotherapy non-small-cell lung cancer prognosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/33959501/
PMC8093620
33959501
Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series
2021